Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
AMNEAL PHARMACEUTICALS, INC. (AMRX), most recent 12 months reported: revenue $3.12B, net income $157.36M, free cash flow $127.83M. Latest balance sheet on file: liquid cash $127.64M, total debt $2.67B, net cash -$2.54B. From SEC filings. More on AMNEAL PHARMACEUTICALS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Jazz Pharmaceuticals plc · Perrigo Company plc · BIOMARIN PHARMACEUTICAL INC · United Therapeutics Corporation · Royalty Pharma plc · SAREPTA THERAPEUTICS, INC. · Alkermes plc. · Phibro Animal Health Corporation
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.